Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Christian

Showing results (531-540 of 559) with videos related to

Pageof 56
Sort By:
The New England Journal of Medicine|April 8, 2024
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic ShockJacob E Møller, Thomas Engstrøm, Lisette O Jensen, et al.
The New England Journal of Medicine|September 1, 2025
Long-Term Outcomes of the DanGer Shock TrialJacob E Møller, Rasmus P Beske, Thomas Engstrøm, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
Journal of the American College of Cardiology|January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyMichael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
European Journal of Heart Failure|May 28, 2025
Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort studyJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
European Heart Journal. Acute Cardiovascular Care|October 24, 2023
Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort studyBenedikt N Beer, Caroline Kellner, Alina Goßling, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Pageof 56

Showing results (531-540 of 559) with videos related to

Sort By:
Pageof 56
The New England Journal of Medicine|April 8, 2024
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic ShockJacob E Møller, Thomas Engstrøm, Lisette O Jensen, et al.
The New England Journal of Medicine|September 1, 2025
Long-Term Outcomes of the DanGer Shock TrialJacob E Møller, Rasmus P Beske, Thomas Engstrøm, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
Journal of the American College of Cardiology|January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyMichael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
European Journal of Heart Failure|May 28, 2025
Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort studyJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
European Heart Journal. Acute Cardiovascular Care|October 24, 2023
Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort studyBenedikt N Beer, Caroline Kellner, Alina Goßling, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Pageof 56